• Thermo Fisher Scientific Introduces Highly Sensitive Research Assays for Measurable Residual Disease Detection in Myeloid Malignancies

    9 days ago - By San Diego Biotechnology

    CARLSBAD, Calif.--Thermo Fisher Scientific today launched a next-generation sequencing -based assay for research in myeloid measurable residual disease. As the first NGS-based tests to support both DNA and RNA input, the Ion Torrent...
    Read more ...